Related Experiment Videos
Morphine-3-glucuronide: silent regulator of morphine actions
A W Lipkowski1, D B Carr, A Langlade
1Department of Anesthesia, Massachusetts General Hospital, Boston 02114.
Abstract:
To assess whether stoichiometric manipulation of morphine (M) metabolism can enhance analgesia or slow the development of M tolerance we co-administered M-3- glucuronide (M3G) during single or repeated doses of morphine in rats. Although M3G itself lacked analgesic activity, co-injection of M3G with M increased and prolonged analgesia beyond that seen with M. In addition, diminution of the acute analgesic effect of M after 3 once-daily doses of M did not occur after daily co-injection of M3G and M. Thus the traditional view that tolerance to the effects of M is due solely to effects mediated through opioid receptors must be broadened to include the contributions of enzyme induction or stoichiometric equilibration of M3G in this process.
Insights
Co-administering morphine-3-glucuronide (M3G) with morphine (M) in rats enhanced and prolonged pain relief. This suggests M3G plays a role in morphine tolerance, broadening our understanding of opioid receptor effects.
Area of Science:
- Pharmacology
- Neuroscience
- Pain Management
Background:
- Morphine (M) is a primary analgesic, but its effectiveness is limited by tolerance.
- Morphine metabolism, particularly the formation of morphine-3-glucuronide (M3G), is implicated in its effects and tolerance.
- The precise role of M3G in modulating morphine analgesia and tolerance remains incompletely understood.
Purpose of the Study:
- To investigate if altering the ratio of morphine to M3G can improve pain relief.
- To determine if co-administration of M3G can prevent or slow the development of morphine tolerance.
- To explore the contribution of M3G to the overall effects of morphine.
Main Methods:
- Rats received single or repeated daily doses of morphine.
- Morphine-3-glucuronide (M3G) was co-administered with morphine in specific stoichiometric ratios.
- Analgesic effects were measured after single and repeated dosing regimens.
- Changes in analgesic response over time were assessed to evaluate tolerance development.
Main Results:
- Morphine-3-glucuronide (M3G) alone did not produce analgesia.
- Co-administration of M3G with morphine (M) significantly increased and prolonged the analgesic effect of M.
- Daily co-administration of M3G and M prevented the typical decrease in acute analgesic effect observed after repeated M doses, indicating a delay in tolerance development.
Conclusions:
- Stoichiometric manipulation of morphine metabolism by co-administering M3G enhances and prolongs analgesia.
- The development of tolerance to morphine is not solely mediated by opioid receptors.
- Enzyme induction or stoichiometric equilibration involving M3G are significant factors in morphine tolerance, necessitating a broader understanding of its mechanisms.